Literature DB >> 32298611

Strategies to Facilitate Translational Advances from Microbiome Surveys.

Amy D Willis1, Samuel S Minot2.   

Abstract

Manipulating the microbiome has enormous potential to treat important human diseases. Microbiome surveys are often used to identify potential therapeutic targets by finding associations between microbial elements and disease status. We argue that many reported associations between the microbiome and disease are incompatible with translational research because they are insufficiently specific. We encourage the clear specification of manipulable microbial elements that can be tested in follow-up randomized experiments, and we provide multiple examples of specific and nonspecific microbial elements.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  microbiome; reproducibility; scientific method; translational science

Mesh:

Year:  2020        PMID: 32298611      PMCID: PMC8118166          DOI: 10.1016/j.tim.2020.02.002

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  7 in total

Review 1.  An introduction to causal inference.

Authors:  Judea Pearl
Journal:  Int J Biostat       Date:  2010-02-26       Impact factor: 0.968

Review 2.  The Human Intestinal Microbiome in Health and Disease.

Authors:  Susan V Lynch; Oluf Pedersen
Journal:  N Engl J Med       Date:  2016-12-15       Impact factor: 91.245

3.  A defined commensal consortium elicits CD8 T cells and anti-cancer immunity.

Authors:  Takeshi Tanoue; Satoru Morita; Damian R Plichta; Ashwin N Skelly; Wataru Suda; Yuki Sugiura; Seiko Narushima; Hera Vlamakis; Iori Motoo; Kayoko Sugita; Atsushi Shiota; Kozue Takeshita; Keiko Yasuma-Mitobe; Dieter Riethmacher; Tsuneyasu Kaisho; Jason M Norman; Daniel Mucida; Makoto Suematsu; Tomonori Yaguchi; Vanni Bucci; Takashi Inoue; Yutaka Kawakami; Bernat Olle; Bruce Roberts; Masahira Hattori; Ramnik J Xavier; Koji Atarashi; Kenya Honda
Journal:  Nature       Date:  2019-01-23       Impact factor: 49.962

4.  A role for bacterial urease in gut dysbiosis and Crohn's disease.

Authors:  Josephine Ni; Ting-Chin David Shen; Eric Z Chen; Kyle Bittinger; Aubrey Bailey; Manuela Roggiani; Alexandra Sirota-Madi; Elliot S Friedman; Lillian Chau; Andrew Lin; Ilana Nissim; Justin Scott; Abigail Lauder; Christopher Hoffmann; Gloriany Rivas; Lindsey Albenberg; Robert N Baldassano; Jonathan Braun; Ramnik J Xavier; Clary B Clish; Marc Yudkoff; Hongzhe Li; Mark Goulian; Frederic D Bushman; James D Lewis; Gary D Wu
Journal:  Sci Transl Med       Date:  2017-11-15       Impact factor: 17.956

5.  Composition of gut microbiota in patients with toxigenic Clostridioides (Clostridium) difficile: Comparison between subgroups according to clinical criteria and toxin gene load.

Authors:  Sung-Hee Han; Joowon Yi; Ji-Hoon Kim; SangWon Lee; Hee-Won Moon
Journal:  PLoS One       Date:  2019-02-20       Impact factor: 3.240

6.  Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease.

Authors:  Yi Duan; Cristina Llorente; Sonja Lang; Katharina Brandl; Huikuan Chu; Lu Jiang; Richard C White; Thomas H Clarke; Kevin Nguyen; Manolito Torralba; Yan Shao; Jinyuan Liu; Adriana Hernandez-Morales; Lauren Lessor; Imran R Rahman; Yukiko Miyamoto; Melissa Ly; Bei Gao; Weizhong Sun; Roman Kiesel; Felix Hutmacher; Suhan Lee; Meritxell Ventura-Cots; Francisco Bosques-Padilla; Elizabeth C Verna; Juan G Abraldes; Robert S Brown; Victor Vargas; Jose Altamirano; Juan Caballería; Debbie L Shawcross; Samuel B Ho; Alexandre Louvet; Michael R Lucey; Philippe Mathurin; Guadalupe Garcia-Tsao; Ramon Bataller; Xin M Tu; Lars Eckmann; Wilfred A van der Donk; Ry Young; Trevor D Lawley; Peter Stärkel; David Pride; Derrick E Fouts; Bernd Schnabl
Journal:  Nature       Date:  2019-11-13       Impact factor: 49.962

7.  Microbiome data distinguish patients with Clostridium difficile infection and non-C. difficile-associated diarrhea from healthy controls.

Authors:  Alyxandria M Schubert; Mary A M Rogers; Cathrin Ring; Jill Mogle; Joseph P Petrosino; Vincent B Young; David M Aronoff; Patrick D Schloss
Journal:  MBio       Date:  2014-05-06       Impact factor: 7.867

  7 in total
  5 in total

1.  Evaluating replicability in microbiome data.

Authors:  David S Clausen; Amy D Willis
Journal:  Biostatistics       Date:  2022-10-14       Impact factor: 5.279

2.  Associations between the Gut Microbiota, Immune Reconstitution, and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Salvatore Fiorenza; Cameron J Turtle
Journal:  Immunometabolism       Date:  2021-01-12

3.  Urogenital Microbiota:Potentially Important Determinant of PD-L1 Expression in Male Patients with Non-muscle Invasive Bladder Cancer.

Authors:  Chunxiao Chen; Zehai Huang; Pengcheng Huang; Kun Li; Jiarong Zeng; Yuehui Wen; Biao Li; Jie Zhao; Peng Wu
Journal:  BMC Microbiol       Date:  2022-01-04       Impact factor: 3.605

4.  Microeukaryotic gut parasites in wastewater treatment plants: diversity, activity, and removal.

Authors:  Jule Freudenthal; Feng Ju; Helmut Bürgmann; Kenneth Dumack
Journal:  Microbiome       Date:  2022-02-09       Impact factor: 14.650

5.  Characterization of the Luminal and Mucosa-Associated Microbiome along the Gastrointestinal Tract: Results from Surgically Treated Preterm Infants and a Murine Model.

Authors:  Ingeborg Klymiuk; Georg Singer; Christoph Castellani; Slave Trajanoski; Beate Obermüller; Holger Till
Journal:  Nutrients       Date:  2021-03-23       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.